Epistaxis News and Research

RSS
New evidence-based clinical practice guideline for nosebleed published

New evidence-based clinical practice guideline for nosebleed published

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Research leads to new potential treatment for Hereditary Hemorrhagic Telangiectasia

Research leads to new potential treatment for Hereditary Hemorrhagic Telangiectasia

Study shows safety, efficacy of intravenous bevacizumab treatment for HHT related bleeding

Study shows safety, efficacy of intravenous bevacizumab treatment for HHT related bleeding

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

Simple saline solution could help alleviate chronic nosebleeds, study shows

Simple saline solution could help alleviate chronic nosebleeds, study shows

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

FDA approves Defitelio to treat hepatic veno-occlusive disease in adults, children

FDA approves Defitelio to treat hepatic veno-occlusive disease in adults, children

New data shows ALS-008176 drug safe and effective against RSV infection

New data shows ALS-008176 drug safe and effective against RSV infection

Latest ENT research to be presented at AAO-HNSF's annual meeting

Latest ENT research to be presented at AAO-HNSF's annual meeting

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes  in CLL/SLL patients

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma